Although several scoring systems based on clinical parameters, such as HAS-BLED or HEMORR2HAGES, have been created to assess the 1-year risk for major bleeding in patients on chronic anticoagulation, they seem inadequate in predicting higher diagnostic yields of small bowel capsule endoscopy (SBCE) or higher rebleeding rates in patients with obscure gastrointestinal bleeding (OGIB). The aim of this study was to evaluate the ability of the new ORBIT score in predicting higher diagnostic yield of SBCE or higher rebleeding rates in chronically anticoagulated patients with OGIB.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Gastrointestinal Endoscopy
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2017 Published by Elsevier Inc.